Listed

BWX Technologies, Inc.: Form 10-Q for the period ended Jun 30, 2019

Filed with the SEC on Aug 5, 2019 and accepted by EDGAR at Aug 5, 2019, 16:47 ET.

Share

Management's discussion and analysis

As filed, 40,976 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS

The following information should be read in conjunction with the unaudited condensed consolidated financial statements and the notes thereto included under Item 1 of this quarterly report on Form 10-Q ("Report") and the audited consolidated financial statements and the related notes and Item 7 "Management's Discussion and Analysis of Financial Condition and Results of Operations" included in our annual report on Form 10-K for the year ended December 31, 2018 (our "2018 10-K").

In this Report, unless the context otherwise indicates, "we," "us" and "our" mean BWX Technologies, Inc. ("BWXT" or the "Company") and its consolidated subsidiaries.

From time to time, our management or persons acting on our behalf make forward-looking statements to inform existing and potential security holders about our Company. Forward-looking statements include those statements that express a belief, expectation or intention, as well as those that are not statements of historical fact, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act. Statements and assumptions regarding expectations and projections of specific projects, our future backlog, revenues, income and capital spending, strategic investments, acquisitions or divestitures, return of capital activities or margin improvement initiatives are examples of forward-looking statements. Forward-looking statements are generally accompanied by words such as "estimate," "project," "predict," "believe," "expect," "anticipate," "plan," "seek," "goal," "could," "intend," "may," "should" or other words that convey the uncertainty of future events or outcomes. In addition, sometimes we will specifically describe a statement as being a forward-looking statement and refer to this cautionary statement.

We have based our forward-looking statements on information currently available to us and our current expectations, estimates and projections about our industries and our Company. We caution that these statements are not guarantees of future performance and you should not rely unduly on them as they involve risks, uncertainties and assumptions that we cannot predict. In addition, we have based many of these forward-looking statements on assumptions about future events that may prove to be inaccurate. While our management considers these statements and assumptions to be reasonable, they are inherently subject to numerous factors, including potentially the risk factors described in the section labeled Item 1A, "Risk Factors" of our 2018 10-K, most of which are difficult to predict and many of which are beyond our control. Accordingly, our actual results may differ materially from the future performance that we have expressed or forecast in our forward-looking statements.

We have discussed many of these factors in more detail elsewhere in this Report and in Item 1A "Risk Factors" in our 2018 10-K. These factors are not necessarily all the factors that could affect us. Unpredictable or unanticipated factors we have not discussed in this Report or in our 2018 10-K could also have material adverse effects on actual results of matters that are the subject of our forward-looking statements. We do not intend to update or review any forward-looking statement or our description of important factors, whether as a result of new information, future events or otherwise, except as required by applicable laws.

GENERAL

We operate in three reportable segments: Nuclear Operations Group, Nuclear Power Group and Nuclear Services Group. In general, we operate in capital-intensive industries and rely on large contracts for a substantial amount of our revenues. We are currently exploring growth strategies across our segments to expand and complement our existing businesses. We would expect to fund these opportunities with cash generated from operations or by raising additional capital through debt, equity or some combination thereof.

Nuclear Operations Group

The revenues of our Nuclear Operations Group segment are largely a function of defense spending by the U.S. Government. Through this segment, we engineer, design and manufacture precision naval nuclear components, reactors and nuclear fuel for the DOE/NNSA's Naval Nuclear Propulsion Program. In addition, we perform development and fabrication activities for missile launch tubes for U.S. Navy submarines. As a supplier of major nuclear components for certain U.S. Government programs, this segment is a significant participant in the defense industry.

Nuclear Power Group

Through this segment, we design and manufacture commercial nuclear steam generators, heat exchangers, pressure vessels, reactor components, and other auxiliary equipment, including containers for the storage of spent nuclear fuel and other high-level nuclear waste. This segment is a leading supplier of nuclear fuel, fuel handling systems, tooling delivery systems and related services for CANDU nuclear power plants. This segment also provides a variety of engineering and in-plant services and is a significant supplier to nuclear power utilities undergoing major refurbishment and plant life extension projects. Additionally, this segment is a leading global manufacturer and supplier of critical medical radioisotopes and radiopharmaceuticals.

Our Nuclear Power Group segment's overall activity primarily depends on the demand and competitiveness of nuclear energy. A significant portion of our Nuclear Power Group segment's operations depend on the timing of maintenance and refueling outages, the cyclical nature of capital expenditures and major refurbishment and life extension projects, as well as the demand for nuclear fuel and fuel handling equipment primarily in the Canadian market, which could cause variability in our financial results.

Nuclear Services Group

Our Nuclear Services Group segment provides various services to the U.S. Government and the commercial nuclear industry primarily in the U.S. The revenues and equity in income of investees under our U.S. Government contracts are largely a function of spending of the U.S. Government and the performance scores we and our consortium partners earn in managing and operating high-consequence operations at U.S. nuclear weapons sites, national laboratories and manufacturing complexes. With its specialized capabilities of full life-cycle management of special materials, facilities and technologies, we believe our Nuclear Services Group segment is well-positioned to continue to participate in the continuing cleanup, operation and management of critical government-owned nuclear sites, laboratories and manufacturing complexes maintained by the DOE, NASA and other federal agencies.

This segment is also engaged in inspection and maintenance services for the commercial nuclear industry primarily in the U.S. These services include steam generator, heat exchanger and balance of plant inspection and servicing as well as high pressure water lancing, non-destructive examination and the development of customized tooling solutions. This segment also develops technology for a variety of applications, including advanced nuclear power sources, and offers complete advanced nuclear fuel and reactor design and engineering, licensing and manufacturing services for new advanced nuclear reactors.

Acquisition of Sotera Health LLC's Nordion Medical Isotope Business

On July 30, 2018, our subsidiary BWXT ITG Canada, Inc. acquired Sotera Health's Nordion medical isotope business (the "MI business"). The MI business is a leading global manufacturer and supplier of critical medical radioisotopes and radiopharmaceuticals for research, diagnostic and therapeutic uses. Its customers include radiopharmaceutical companies, hospitals and radiopharmacies. Its primary operations are located in Kanata, Ontario, Canada and Vancouver, British Columbia, Canada. This acquisition added approximately 150 highly trained and experienced personnel, two specialized production centers and a uniquely licensed infrastructure. In addition to the growing portfolio of radioisotope products we acquired, the MI business will be the platform from which we plan to launch our Molybdenum-99 product line and a number of future radioisotope-based imaging, diagnostic and therapeutic products. This business is reported as part of our Nuclear Power Group segment.

Critical Accounting Policies and Estimates

For a summary of the critical accounting policies and estimates that we use in the preparation of our unaudited condensed consolidated financial statements, see Item 7 "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our 2018 10-K. There have been no material changes to our policies during the six months ended June 30, 2019 with the exception of changes to Financial Accounting Standards Board ("FASB") Topic Leases as described in the notes to the condensed consolidated financial statements in Part I of this Report.

Accounting for Contracts

On certain of our performance obligations, we recognize revenue over time. In accordance with FASB Topic Revenue from Contracts with Customers, we are required to estimate the total amount of costs on these performance obligations. As of June 30, 2019, we have provided for the estimated costs to complete all of our ongoing contracts. However, it is possible that current estimates could change due to unforeseen events, which could result in adjustments to overall contract revenues and costs. A principal risk on fixed-price contracts is that revenue from the customer is insufficient to cover increases in our costs. It is possible that current estimates could materially change for various reasons, including, but not limited to, fluctuations in forecasted labor productivity or steel and other raw material prices. In some instances, we guarantee completion dates related to our projects or provide performance guarantees. Increases in costs on our fixed-price contracts could have a material adverse impact on our consolidated results of operations, financial condition and cash flows. Alternatively, reductions in overall contract costs at completion could materially improve our consolidated results of operations, financial condition and cash flows. During the three months ended June 30, 2019 and 2018, we recognized net changes in estimates related to contracts that recognize revenue over time, which increased operating income by approximately $18.9 million and $9.2 million, respectively. During the six months ended June 30, 2019 and 2018, we recognized net changes in estimates related to contracts that recognize revenue over time, which increased operating income by approximately $23.7 million and $14.5 million, respectively.

RESULTS OF OPERATIONS – THREE AND SIX MONTHS ENDED JUNE 30, 2019 VS. THREE AND SIX MONTHS ENDED JUNE 30, 2018

Selected financial highlights are presented in the table below:

(In thousands)

REVENUES: Three Months Ended June 30, 2019 2018 $ Change Six Months Ended June 30, 2019 2018 $ Change
Nuclear Operations Group $358,352 $332,140 $26,212 $663,153 $648,771 $14,382
Nuclear Power Group 86,639 75,697 10,942 171,038 188,513 (17,475)
Nuclear Services Group 29,829 32,596 (2,767) 58,923 62,629 (3,706)
Adjustments and Eliminations (3,589) (1,512) (2,077) (5,429) (3,529) (1,900)
$471,231 $438,921 $32,310 $887,685 $896,384 $(8,699)
OPERATING INCOME:
Nuclear Operations Group $75,226 $67,046 $8,180 $132,851 $134,703 $(1,852)
Nuclear Power Group 14,883 7,810 7,073 27,466 29,574 (2,108)
Nuclear Services Group 1,490 3,511 (2,021) 3,061 4,688 (1,627)
Other (6,744) (4,357) (2,387) (12,840) (8,400) (4,440)
$84,855 $74,010 $10,845 $150,538 $160,565 $(10,027)
Unallocated Corporate (4,320) (2,461) (1,859) (6,359) (9,128) 2,769
Total Operating Income $80,535 $71,549 $8,986 $144,179 $151,437 $(7,258)

Consolidated Results of Operations

Three months ended June 30, 2019 vs. 2018

Consolidated revenues increased 7.4%, or $32.3 million, to $471.2 million in the three months ended June 30, 2019 compared to $438.9 million for the corresponding period in 2018, due to increases in revenues from our Nuclear Operations Group and Nuclear Power Group segments totaling $26.2 million and $10.9 million, respectively. These increases were partially offset by a decrease in revenues in our Nuclear Services Group segment of $2.8 million.

Consolidated operating income increased $9.0 million to $80.5 million in the three months ended June 30, 2019 compared to $71.5 million for the corresponding period of 2018. Operating income in our Nuclear Operations Group and Nuclear Power Group segments increased by $8.2 million and $7.1 million, respectively. These increases were partially offset by decreases in operating income in our Nuclear Services Group and Other segments of $2.0 million and $2.4 million, respectively, as well as higher unallocated corporate expenses of $1.9 million.

Six months ended June 30, 2019 vs. 2018

Consolidated revenues decreased 1.0%, or $8.7 million, to $887.7 million in the six months ended June 30, 2019 compared to $896.4 million for the corresponding period in 2018, due to decreases in revenues from our Nuclear Power Group and Nuclear Services Group segments totaling $17.5 million and $3.7 million, respectively. These decreases were partially offset by an increase in our Nuclear Operations Group segment of $14.4 million.

Consolidated operating income decreased $7.3 million to $144.2 million in the six months ended June 30, 2019 compared to $151.4 million for the corresponding period of 2018. Operating income in our Nuclear Operations Group, Nuclear Power Group, Nuclear Services Group and Other segments decreased by $1.9 million, $2.1 million, $1.6 million and $4.4 million, respectively. These decreases were partially offset by lower unallocated corporate expenses of $2.8 million when compared to the corresponding period of 2018.

Nuclear Operations Group

(In thousands)

Three Months Ended June 30, 2019 2018 $ Change Six Months Ended June 30, 2019 2018 $ Change
Revenues $358,352 $332,140 $26,212 $663,153 $648,771 $14,382
Operating Income $75,226 $67,046 $8,180 $132,851 $134,703 $(1,852)
% of Revenues 21.0% 20.2% 20.0% 20.8%

Three months ended June 30, 2019 vs. 2018

Revenues increased 7.9%, or $26.2 million, to $358.4 million in the three months ended June 30, 2019 compared to $332.1 million for the corresponding period of 2018. The increase was primarily attributable to increased activity in the manufacturing of nuclear components for U.S. Government programs.

Operating income increased $8.2 million to $75.2 million in the three months ended June 30, 2019 compared to $67.0 million for the corresponding period of 2018. The increase in operating income was primarily due to the changes in revenues noted above.

Six months ended June 30, 2019 vs. 2018

Revenues increased 2.2%, or $14.4 million, to $663.2 million in the six months ended June 30, 2019 compared to $648.8 million for the corresponding period of 2018. This increase was primarily attributable to increased activity in the manufacturing of nuclear components for U.S. Government programs. These increases were partially offset by the timing of the procurement of certain long-lead materials when compared to the corresponding period of 2018.

Operating income decreased $1.9 million to $132.9 million in the six months ended June 30, 2019 compared to $134.7 million for the corresponding period of 2018. The decrease was primarily driven by higher expenses associated with onboarding employees to meet expected increased volume demands, which were partially offset by the operating income impact of the increases in revenues noted above.

Nuclear Power Group

(In thousands)

Three Months Ended June 30, 2019 2018 $ Change Six Months Ended June 30, 2019 2018 $ Change
Revenues $86,639 $75,697 $10,942 $171,038 $188,513 $(17,475)
Operating Income $14,883 $7,810 $7,073 $27,466 $29,574 $(2,108)
% of Revenues 17.2% 10.3% 16.1% 15.7%

Three months ended June 30, 2019 vs. 2018

Revenues increased 14.5%, or $10.9 million, to $86.6 million in the three months ended June 30, 2019 compared to $75.7 million for the corresponding period of 2018. The increase was primarily attributable to increased activity in our nuclear components business of $22.4 million related to increased activity associated with a major steam generator design and supply contract and additional volume related to component replacement production activities. This segment also experienced an increase in revenues of $10.1 million associated with our MI business, which was acquired in the third quarter of 2018. These increases were partially offset by a decrease in revenues of $21.5 million from a decline in the amount of in-plant inspection, maintenance and modification services resulting from a lower volume of outage projects when compared to the prior year.

Operating income increased $7.1 million to $14.9 million in the three months ended June 30, 2019 compared to $7.8 million for the corresponding period of 2018, primarily attributable to the net increase in revenues noted above in addition to net favorable changes in estimates related to certain long-term contracts.

Six months ended June 30, 2019 vs. 2018

Revenues decreased 9.3%, or $17.5 million, to $171.0 million in the six months ended June 30, 2019 compared to $188.5 million for the corresponding period of 2018. The decrease was primarily attributable to a $31.7 million decline in revenues related to the amount of in-plant inspection, maintenance and modification services resulting from a lower volume of outage projects when compared to the prior year. In addition, we experienced a decline in revenues associated with the China steam generator project, which is nearing completion. These decreases were partially offset by increased activity associated with a major steam generator design and supply contract and additional volume related to component replacement production activities, as well as a $20.6 million increase in revenues associated with our MI business, which was acquired in the third quarter of 2018.

Operating income decreased $2.1 million to $27.5 million in the six months ended June 30, 2019 compared to $29.6 million for the corresponding period of 2018, primarily attributable to the net decrease in revenues noted above.

Nuclear Services Group

(In thousands)

Three Months Ended June 30, 2019 2018 $ Change Six Months Ended June 30, 2019 2018 $ Change
Revenues $29,829 $32,596 $(2,767) $58,923 $62,629 $(3,706)
Operating Income $1,490 $3,511 $(2,021) $3,061 $4,688 $(1,627)
% of Revenues 5.0% 10.8% 5.2% 7.5%

Three months ended June 30, 2019 vs. 2018

Revenues decreased 8.5%, or $2.8 million, to $29.8 million in the three months ended June 30, 2019 compared to $32.6 million for the corresponding period of 2018. The decrease was primarily attributable to lower levels of cost-reimbursable activities at a joint venture site in New Mexico that was transitioned to us during the prior year in addition to performing fewer commercial nuclear maintenance outages in the U.S. when compared to the same period in the prior year.

Operating income decreased $2.0 million to $1.5 million in the three months ended June 30, 2019 compared to $3.5 million for the corresponding period of 2018. The decrease was attributable to the operating income impact of the changes in revenues noted above in addition to higher selling, general and administrative expenses related to business development activities caused by the timing of proposal activities.

Six months ended June 30, 2019 vs. 2018

Revenues decreased 5.9%, or $3.7 million, to $58.9 million in the six months ended June 30, 2019 compared to $62.6 million for the corresponding period of 2018. The decrease was primarily attributable to lower levels of cost-reimbursable activities at a joint venture site in New Mexico that was transitioned to us during the prior year in addition to performing fewer commercial nuclear maintenance outages in the U.S. when compared to the same period in the prior year.

Operating income decreased $1.6 million to $3.1 million in the six months ended June 30, 2019 compared to $4.7 million for the corresponding period of 2018. The decrease was attributable to the operating income impact of the changes in revenues noted above in addition to higher selling, general and administrative expenses related to business development activities caused by the timing of proposal activities.

Other

(In thousands)

Three Months Ended June 30, 2019 2018 $ Change Six Months Ended June 30, 2019 2018 $ Change
Operating Income $(6,744) $(4,357) $(2,387) $(12,840) $(8,400) $(4,440)

Operating income decreased $2.4 million and $4.4 million in the three and six months ended June 30, 2019, respectively, primarily due to increases in research and development activities related to our medical and industrial radioisotope capabilities and other nuclear technologies when compared to the corresponding periods of the prior year.

Unallocated Corporate

Unallocated corporate expenses increased $1.9 million to $4.3 million for the three months ended June 30, 2019 compared to $2.5 million for the corresponding period of 2018. This increase was primarily due to higher levels of stock-based compensation in the current year.

Unallocated corporate expenses decreased $2.8 million to $6.4 million for the six months ended June 30, 2019 compared to $9.1 million for the corresponding period of 2018. This decrease was primarily due to higher levels of legal and consulting costs associated with due diligence activities conducted in the prior year.

Other Income Statement Items

Other income (expense) decreased $10.5 million to a loss of $2.8 million in the three months ended June 30, 2019, as compared to a gain of $7.7 million for the corresponding period of 2018, due primarily to $6.0 million of gains related to derivative instruments not designated as hedges in the prior year and an increase in net periodic benefit cost.

Other income (expense) decreased $16.4 million to a loss of $3.6 million in the six months ended June 30, 2019, as compared to a gain of $12.8 million for the corresponding period of 2018, due primarily to $6.0 million of gains related to derivative instruments not designated as hedges in the prior year and an increase in net periodic benefit cost. In addition, we experienced an increase in interest expense of $6.8 million associated with higher levels of long-term debt when compared to the prior year.

Provision for Income Taxes

(In thousands)

Three Months Ended June 30, 2019 2018 $ Change Six Months Ended June 30, 2019 2018 $ Change
Income before Provision for Income Taxes $77,734 $79,227 $(1,493) $140,611 $164,243 $(23,632)
Provision for Income Taxes $18,734 $18,493 $241 $32,501 $37,096 $(4,595)
Effective Tax Rate 24.1% 23.3% 23.1% 22.6%

We operate primarily in the U.S. and Canada, and we recognize our U.S. income tax provision based on the U.S. federal statutory rate of 21% and our Canadian tax provision based on the Canadian local statutory rate of approximately 25%.

Our effective tax rate for the three months ended June 30, 2019 was 24.1% as compared to 23.3% for the three months ended June 30, 2018. Our effective tax rate for the six months ended June 30, 2019 was 23.1% as compared to 22.6% for the six months ended June 30, 2018. The effective tax rates for the three and six months ended June 30, 2019 and 2018 were higher than the U.S. corporate income tax rate of 21% primarily due to state income taxes within the U.S. and the unfavorable rate differential associated with our Canadian earnings. Our effective tax rates for the six months ended June 30, 2019 and 2018 were favorably impacted by benefits recognized for excess tax benefits related to employee share-based payments of $1.8 million and $2.4 million, respectively.

Backlog

Backlog represents the dollar amount of revenue we expect to recognize in the future from contracts awarded and in progress. Not all of our expected revenue from a contract award is recorded in backlog for a variety of reasons, including that some projects are awarded and completed within the same fiscal quarter.

Our backlog is equal to our remaining performance obligations under contracts that meet the criteria in FASB Topic Revenue from Contracts with Customers, as discussed in Note 3 to our condensed consolidated financial statements included in this Report. It is possible that our methodology for determining backlog may not be comparable to methods used by other companies.

We are subject to the budgetary and appropriations cycle of the U.S. Government as it relates to our Nuclear Operations Group and Nuclear Services Group segments. Backlog may not be indicative of future operating results, and projects in our backlog may be cancelled, modified or otherwise altered by customers.

June 30, 2019 (In approximate millions) December 31, 2018
Nuclear Operations Group $3,706 $2,637
Nuclear Power Group 751 804
Nuclear Services Group 48 38
Total Backlog $4,505 $3,479

We do not include the value of our unconsolidated joint venture contracts in backlog. These unconsolidated joint ventures are included in our Nuclear Services Group segment.

Of the June 30, 2019 backlog, we expect to recognize revenues as follows:

2019 (In approximate millions) 2020 Thereafter Total
Nuclear Operations Group $658 $1,085 $1,963 $3,706
Nuclear Power Group 158 139 454 751
Nuclear Services Group 31 5 12 48
Total Backlog $847 $1,229 $2,429 $4,505

At June 30, 2019, Nuclear Operations Group backlog with the U.S. Government was $3,205.6 million, $151.3 million of which had not yet been funded.

At June 30, 2019, Nuclear Power Group had no backlog with the U.S. Government.

At June 30, 2019, Nuclear Services Group backlog with the U.S. Government was $27.0 million, all of which was funded.

Major new awards from the U.S. Government are typically received following Congressional approval of the budget for the Government's next fiscal year, which starts October 1, and may not be awarded to us before the end of the calendar year. Due to the fact that most contracts awarded by the U.S. Government are subject to these annual funding approvals, the total values of the underlying programs are significantly larger. In March 2019, we received a nuclear component and fuel award from the U.S. Government with a combined value exceeding $2.1 billion, inclusive of unexercised options, approximately $1.5 billion of which had been added to backlog as of June 30, 2019. The value of unexercised options excluded from backlog as of June 30, 2019 was approximately $0.6 billion, the majority of which is expected to be exercised in 2020, subject to annual Congressional appropriations.

Liquidity and Capital Resources

Credit Facility

On May 24, 2018, we and certain of our subsidiaries entered into a credit agreement (the "Credit Facility") with Wells Fargo Bank, N.A., as administrative agent, and the other lenders party thereto. The Credit Facility includes a $500.0 million senior secured revolving credit facility (the "Revolving Credit Facility"), a $50.0 million U.S. dollar senior secured term loan A made available to the Company (the "USD Term Loan") and a $250.0 million (U.S. dollar equivalent) Canadian dollar senior secured term loan A made available to BWXT Canada Ltd. (the "CAD Term Loan"). All obligations under the Credit Facility are scheduled to mature on May 24, 2023. The proceeds of loans under the Credit Facility are available for working capital needs and other general corporate purposes.

The Credit Facility allows for additional parties to become lenders and, subject to certain conditions, for the increase of the commitments under the Credit Facility, subject to an aggregate maximum for all additional commitments of (1) the greater of (a) $250 million and (b) 65% of EBITDA, as defined in the Credit Facility, for the last four full fiscal quarters, plus (2) all voluntary prepayments of term loans, plus (3) additional amounts provided the Company is in compliance with a pro forma first lien leverage ratio test of less than or equal to 2.50 to 1.00.

The Company's obligations under the Credit Facility are guaranteed, subject to certain exceptions, by substantially all of the Company's present and future wholly owned domestic restricted subsidiaries. The obligations of BWXT Canada Ltd. under the Credit Facility are guaranteed, subject to certain exceptions, by substantially all of the Company's present and future wholly owned Canadian and domestic restricted subsidiaries.

The Credit Facility is secured by first-priority liens on certain assets owned by the Company (other than its subsidiaries comprising its Nuclear Operations Group segment and a portion of its Nuclear Services Group segment); provided that (1) the Company's domestic obligations are only secured by assets and property of the domestic loan parties and (2) the obligations of BWXT Canada Ltd. and the Canadian guarantors are secured by assets and property of the Canadian guarantors and the domestic loan parties.

The Credit Facility requires interest payments on revolving loans on a periodic basis until maturity. We began making quarterly amortization payments on the USD Term Loan and the CAD Term Loan in amounts equal to 1.25% of the initial aggregate principal amount of each term loan in the third quarter of 2018. We may prepay all loans under the Credit Facility at any time without premium or penalty (other than customary Eurocurrency breakage costs), subject to notice requirements.

The Credit Facility includes financial covenants that are tested on a quarterly basis, based on the rolling four-quarter period that ends on the last day of each fiscal quarter. The maximum permitted leverage ratio is 4.00 to 1.00, which may be increased to 4.50 to 1.00 for up to four consecutive fiscal quarters after a material acquisition. The minimum consolidated interest coverage ratio is 3.00 to 1.00. In addition, the Credit Facility contains various restrictive covenants, including with respect to debt, liens, investments, mergers, acquisitions, dividends, equity repurchases and asset sales. As of June 30, 2019, we were in compliance with all covenants set forth in the Credit Facility.

Outstanding loans under the Credit Facility will bear interest at our option at either (1) the Eurocurrency rate plus a margin ranging from 1.25% to 2.0% per year or (2) the base rate or Canadian index rate, as applicable (described in the Credit Facility as the highest of (a) with respect to the base rate only, the federal funds rate plus 0.5%, (b) the one-month Eurocurrency rate plus 1.0% and (c) the administrative agent's prime rate or the Canadian prime rate, as applicable), plus, in each case, a margin ranging from 0.25% to 1.0% per year. We are charged a commitment fee on the unused portion of the Revolving Credit Facility, and that fee ranges from 0.15% to 0.275% per year. Additionally, we are charged a letter of credit fee of between 1.25% and 2.0% per year with respect to the amount of each financial letter of credit issued under the Credit Facility, and a letter of credit fee of between 0.75% and 1.2% per year with respect to the amount of each performance letter of credit issued under the Credit Facility. The applicable margin for loans, the commitment fee and the letter of credit fees set forth above will vary quarterly based on our leverage ratio. Based on the leverage ratio applicable at June 30, 2019, the margin for Eurocurrency rate and base rate or Canadian index rate loans was 1.5% and 0.5%, respectively, the letter of credit fee for financial letters of credit and performance letters of credit was 1.5% and 0.9%, respectively, and the commitment fee for the unused portion of the Revolving Credit Facility was 0.225%.

As of June 30, 2019, borrowings outstanding totaled $279.2 million and $200.0 million under our term loans and revolving line of credit, respectively, and letters of credit issued under the Credit Facility totaled $65.9 million. As a result, we had $234.1 million available for borrowings or to meet letter of credit requirements as of June 30, 2019. As of June 30, 2019, the weighted-average interest rate on outstanding borrowings under our Credit Facility was 3.69%.

The Credit Facility generally includes customary events of default for a secured credit facility, some of which allow for an opportunity to cure. Under the Credit Facility, (1) if an event of default relating to bankruptcy or other insolvency events occurs, all related obligations will immediately become due and payable; (2) if any other event of default exists, the lenders will be permitted to accelerate the maturity of the related obligations outstanding; and (3) if any event of default exists, the lenders will be permitted to terminate their commitments thereunder and exercise other rights and remedies, including the commencement of foreclosure or other actions against the collateral.

If any default occurs under the Credit Facility, or if we are unable to make any of the representations and warranties in the Credit Facility, we will be unable to borrow funds or have letters of credit issued under the Credit Facility.

Senior Notes

We issued $400.0 million aggregate principal amount of 5.375% senior notes due 2026 (the "Senior Notes") pursuant to an indenture dated May 24, 2018 (the "Indenture"), among the Company, certain of our subsidiaries, as guarantors, and U.S. Bank National Association, as trustee. The Senior Notes are guaranteed by each of the Company's present and future direct and indirect wholly owned domestic subsidiaries that is a guarantor under the Credit Facility.

Interest on the Senior Notes is payable semi-annually in cash in arrears on January 15 and July 15 of each year, which commenced on July 15, 2018, at a rate of 5.375% per annum. The Senior Notes will mature on July 15, 2026.

The Company may redeem the Senior Notes, in whole or in part, at any time on or after July 15, 2021 at established redemption prices. At any time prior to July 15, 2021, the Company may also redeem up to 40% of the Senior Notes with net cash proceeds of certain equity offerings at a redemption price equal to 105.375% of the principal amount of the Senior Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date. In addition, at any time prior to July 15, 2021, the Company may redeem the Senior Notes, in whole or in part, at a redemption price equal to 100% of the principal amount of the Senior Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date plus an applicable "make-whole" premium.

The Indenture contains customary events of default, including, among other things, payment default, failure to comply with covenants or agreements contained in the Indenture or the Senior Notes and certain provisions related to bankruptcy events. The Indenture also contains customary negative covenants. As of June 30, 2019, we were in compliance with all covenants and agreements set forth in the Indenture and the Senior Notes.

Other Arrangements

We have posted surety bonds to support regulatory and contractual obligations for certain decommissioning responsibilities, projects and legal matters. We utilize bonding facilities to support such obligations, but the issuance of bonds under those facilities is typically at the surety's discretion. Although there can be no assurance that we will maintain our surety bonding capacity, we believe our current capacity is adequate to support our existing requirements for the next twelve months. In addition, these bonds generally indemnify the beneficiaries should we fail to perform our obligations under the applicable agreements. We, and certain of our subsidiaries, have jointly executed general agreements of indemnity in favor of surety underwriters relating to surety bonds those underwriters issue. As of June 30, 2019, bonds issued and outstanding under these arrangements totaled approximately $67.7 million.

Long-term Benefit Obligations

Our unfunded pension and postretirement benefit obligations totaled $190.2 million at June 30, 2019. These long-term liabilities are expected to require use of our resources to satisfy future funding obligations. Based largely on statutory funding requirements, we expect to make contributions of approximately $4.5 million for the remainder of 2019 related to our pension and postretirement plans. We may also make additional contributions based on a variety of factors including, but not limited to, tax planning, evaluation of funded status and risk mitigation strategies.

Other

Our domestic and foreign cash and cash equivalents, restricted cash and cash equivalents and investments as of June 30, 2019 and December 31, 2018 were as follows:

(In thousands)

June 30, 2019 December 31, 2018
Domestic $38,832 $37,108
Foreign 15,395 10,279
Total $54,227 $47,387

Our working capital increased by $106.9 million to $272.0 million at June 30, 2019 from $165.1 million at December 31, 2018, primarily attributable to changes in net contracts in progress and advance billings due to the timing of project cash flows and a decrease in current liabilities primarily associated with the payment of accrued incentives during the six months ended June 30, 2019.

Our net cash provided by operations increased by $29.8 million to $47.1 million in the six months ended June 30, 2019, compared to the $17.3 million in the six months ended June 30, 2018. The increase in cash provided by operations was primarily attributable to a decrease in pension contributions when compared to the same period in the prior year.

Our net cash used in investing activities increased by $34.3 million to $75.7 million in the six months ended June 30, 2019, compared to $41.4 million in the six months ended June 30, 2018. The increase was primarily attributable to an increase in purchases of property, plant and equipment of $41.7 million, which was partially offset by a decrease in net investments in equity method investees of $9.8 million.

Our net cash provided by financing activities decreased by $114.4 million to $33.3 million in the six months ended June 30, 2019, compared to $147.7 million in the six months ended June 30, 2018. The decrease was primarily attributable to a decrease in net borrowings of $97.3 million and an increase in repurchases of common shares of $20.0 million.

At June 30, 2019, we had restricted cash and cash equivalents totaling $7.1 million, $2.7 million of which was held for future decommissioning of facilities (which is included in other assets on our condensed consolidated balance sheets) and $4.3 million of which was held to meet reinsurance reserve requirements of our captive insurer.

At June 30, 2019, we had short-term and long-term investments with a fair value of $12.7 million. Our investment portfolio consists primarily of U.S. Government and agency securities, corporate bonds and equities, mutual funds and asset-backed securities. Our debt securities are carried at fair value and are either classified as trading, with unrealized gains and losses reported in earnings, or as available-for-sale, with unrealized gains and losses, net of tax, being reported as a component of other comprehensive income. Our equity securities are carried at fair value with the unrealized gains and losses reported in earnings.

Based on our liquidity position, we believe we have sufficient cash and letter of credit and borrowing capacity to fund our operating requirements for at least the next 12 months.

Market risk

As filed, 127 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Our exposures to market risks have not changed materially from those disclosed in Item 7A included in Part II of our 2018 10-K.

Controls and procedures

As filed, 1,994 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

As of the end of the period covered by this quarterly report, we carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as that term is defined in Rules 13a-15(e) and 15d-15(e) adopted by the SEC under the Securities Exchange Act of 1934, as amended (the "Exchange Act")). This evaluation was conducted under the supervision and with the participation of management, including our Chief Executive Officer and Chief Financial Officer. Our disclosure controls and procedures were developed through a process in which our management applied its judgment in assessing the costs and benefits of such controls and procedures, which, by their nature, can provide only reasonable assurance regarding the control objectives. You should note that the design of any system of disclosure controls and procedures is based in part upon various assumptions about the likelihood of future events, and we cannot assure you that any design will succeed in achieving its stated goals under all potential future conditions, regardless of how remote. Based on the evaluation referred to above, our Chief Executive Officer and Chief Financial Officer concluded that the design and operation of our disclosure controls and procedures are effective as of June 30, 2019 to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission, and such information is accumulated and communicated to management as appropriate to allow timely decisions regarding disclosure. There has been no change in our internal control over financial reporting during the quarter ended June 30, 2019 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II

OTHER INFORMATION

Risk factors

As filed, 322 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

In addition to the other information in this report, the other factors presented in Item 1A Risk Factors in our 2018 10-K are some of the factors that could materially affect our business, financial condition or future results. There have been no material changes to our risk factors from those disclosed in our 2018 10-K.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2019-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2019-04-01 to 2019-06-30$471.2mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue6 months2019-01-01 to 2019-06-30$887.7mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2019-04-01 to 2019-06-30$338.0mus-gaap:CostOfRevenue
Cost of revenue6 months2019-01-01 to 2019-06-30$641.7mus-gaap:CostOfRevenue
Research and development3 months2019-04-01 to 2019-06-30$5.3mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2019-01-01 to 2019-06-30$10.5mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2019-04-01 to 2019-06-30$54.1mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2019-01-01 to 2019-06-30$105.7mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2019-04-01 to 2019-06-30$80.5mus-gaap:OperatingIncomeLoss
Operating income6 months2019-01-01 to 2019-06-30$144.2mus-gaap:OperatingIncomeLoss
Interest expense3 months2019-04-01 to 2019-06-30$9.5mus-gaap:InterestExpense
Interest expense6 months2019-01-01 to 2019-06-30$18.2mus-gaap:InterestExpense
Income tax3 months2019-04-01 to 2019-06-30$18.7mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2019-01-01 to 2019-06-30$32.5mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2019-04-01 to 2019-06-30$58.9mus-gaap:NetIncomeLoss
Net income6 months2019-01-01 to 2019-06-30$107.9mus-gaap:NetIncomeLoss
Diluted EPS3 months2019-04-01 to 2019-06-30$0.62us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2019-01-01 to 2019-06-30$1.13us-gaap:EarningsPerShareDiluted
Basic EPS3 months2019-04-01 to 2019-06-30$0.62us-gaap:EarningsPerShareBasic
Basic EPS6 months2019-01-01 to 2019-06-30$1.13us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2019-04-01 to 2019-06-3095,677,204 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2019-01-01 to 2019-06-3095,749,280 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2019-01-01 to 2019-06-30$47.1mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2019-01-01 to 2019-06-30$75.7mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid6 months2019-01-01 to 2019-06-30$33.0mus-gaap:PaymentsOfDividendsCommonStock
Share repurchases6 months2019-01-01 to 2019-06-30$20.0mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2019-06-30$34.4mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2019-06-30$587.4mus-gaap:AssetsCurrent
Total assetsAt period end2019-06-30$1.76bnus-gaap:Assets
Current liabilitiesAt period end2019-06-30$315.4mus-gaap:LiabilitiesCurrent
Long-term debtAt period end2019-06-30$855.7mus-gaap:LongTermDebtNoncurrent
Shareholders' equityAt period end2019-06-30$294.1mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001486957-19-000034. Last ingested by Listed: Nov 14, 2026, 19:14 ET. Listed shows no prices and gives no investment advice.